Recent work has also demonstrated that a different structurally unrelated highly specific inhibitor of the MLL1-menin interaction, VTP50469, is active in the low nanomolar range and suppressed MLL-target gene expression and cell proliferation in models of MLL-rearranged leukemia. This evidence concerns the gene MEN1 and leukemia.